Cargando…
Understanding and using AlloSure donor derived cell-free DNA
Renal transplant is a lifesaving and cost-effective intervention for patients with End Stage Renal Failure. Yet it is often regarded as replacement therapy rather than a cure given the overall failure rate over time. With a shortage of organs, this global issue has been further compounded by increas...
Autores principales: | Seeto, R. K., Fleming, J. N., Dholakia, S., Dale, B. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429580/ https://www.ncbi.nlm.nih.gov/pubmed/32683591 http://dx.doi.org/10.1007/s12551-020-00713-5 |
Ejemplares similares
-
Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients
por: Dale, Bethany L, et al.
Publicado: (2021) -
Adding Insult on Injury: Immunogenic Role for Donor-derived Cell-free DNA?
por: Dholakia, Shamik, et al.
Publicado: (2020) -
Comparison of the ImmunoCAP Assay and AdvanSure™ AlloScreen Advanced Multiplex Specific IgE Detection Assay
por: Park, Kyung Hee, et al.
Publicado: (2017) -
Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney Transplantation
por: Pai, Akshta, et al.
Publicado: (2021) -
AlloReverse: multiscale understanding among hierarchical allosteric regulations
por: Zha, Jinyin, et al.
Publicado: (2023)